Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperoxia | 24 | 2023 | 136 | 4.020 |
Why?
|
| Cytochrome P-450 CYP1A1 | 18 | 2023 | 82 | 2.930 |
Why?
|
| Bronchopulmonary Dysplasia | 7 | 2020 | 222 | 1.710 |
Why?
|
| Lung Injury | 11 | 2023 | 126 | 1.700 |
Why?
|
| Acute Lung Injury | 9 | 2018 | 69 | 1.520 |
Why?
|
| beta-Naphthoflavone | 4 | 2017 | 11 | 1.450 |
Why?
|
| Cytochrome P-450 CYP1A2 | 11 | 2023 | 47 | 1.390 |
Why?
|
| Lung | 17 | 2023 | 1535 | 1.170 |
Why?
|
| Oxygen | 9 | 2023 | 548 | 1.050 |
Why?
|
| Animals, Newborn | 9 | 2018 | 1021 | 0.670 |
Why?
|
| Pulmonary Alveoli | 4 | 2017 | 139 | 0.620 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 419 | 0.610 |
Why?
|
| Infant, Premature | 5 | 2020 | 872 | 0.610 |
Why?
|
| Oxidative Stress | 9 | 2021 | 791 | 0.560 |
Why?
|
| Quercetin | 1 | 2018 | 11 | 0.540 |
Why?
|
| Cytochrome P-450 CYP1B1 | 4 | 2018 | 30 | 0.500 |
Why?
|
| Vitamin A Deficiency | 1 | 2016 | 11 | 0.470 |
Why?
|
| Vitamin A | 1 | 2016 | 58 | 0.470 |
Why?
|
| Conjunctival Diseases | 1 | 2016 | 31 | 0.460 |
Why?
|
| Optic Atrophy | 1 | 2016 | 42 | 0.450 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 3 | 2021 | 25 | 0.440 |
Why?
|
| Receptors, Aryl Hydrocarbon | 7 | 2016 | 65 | 0.440 |
Why?
|
| Benzo(a)pyrene | 1 | 2014 | 28 | 0.410 |
Why?
|
| Vision Disorders | 1 | 2016 | 191 | 0.410 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 573 | 0.370 |
Why?
|
| Fetus | 1 | 2014 | 568 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 13 | 2023 | 4738 | 0.320 |
Why?
|
| Animals | 29 | 2023 | 33912 | 0.320 |
Why?
|
| Blotting, Western | 7 | 2017 | 1013 | 0.310 |
Why?
|
| Gene Expression Regulation, Enzymologic | 6 | 2016 | 242 | 0.310 |
Why?
|
| Liver | 8 | 2015 | 1796 | 0.310 |
Why?
|
| Mice | 20 | 2023 | 18301 | 0.300 |
Why?
|
| Mice, Knockout | 12 | 2023 | 3819 | 0.300 |
Why?
|
| Cytochrome P-450 Enzyme System | 3 | 2023 | 104 | 0.290 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 2 | 2023 | 82 | 0.270 |
Why?
|
| DNA Adducts | 3 | 2014 | 70 | 0.250 |
Why?
|
| Infant, Newborn | 8 | 2023 | 8635 | 0.240 |
Why?
|
| Tretinoin | 1 | 2006 | 95 | 0.230 |
Why?
|
| Transcriptome | 3 | 2017 | 1103 | 0.220 |
Why?
|
| Rats, Inbred F344 | 3 | 2014 | 99 | 0.220 |
Why?
|
| Neutrophil Infiltration | 6 | 2015 | 63 | 0.210 |
Why?
|
| Sex Characteristics | 2 | 2017 | 323 | 0.200 |
Why?
|
| Rats | 6 | 2014 | 3370 | 0.190 |
Why?
|
| Nitric Oxide | 1 | 2006 | 471 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 4 | 2017 | 1207 | 0.180 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 2323 | 0.170 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2023 | 237 | 0.170 |
Why?
|
| Omeprazole | 2 | 2011 | 125 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1205 | 0.150 |
Why?
|
| Adenoviridae Infections | 1 | 2000 | 75 | 0.150 |
Why?
|
| Methylcholanthrene | 2 | 2010 | 18 | 0.140 |
Why?
|
| Enzyme Induction | 4 | 2011 | 92 | 0.140 |
Why?
|
| Trachea | 1 | 2000 | 209 | 0.140 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 96 | 0.130 |
Why?
|
| Organ Size | 4 | 2015 | 407 | 0.120 |
Why?
|
| Pregnancy | 4 | 2023 | 7512 | 0.120 |
Why?
|
| Humans | 19 | 2023 | 131163 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 197 | 0.120 |
Why?
|
| DNA Damage | 1 | 2018 | 511 | 0.110 |
Why?
|
| Proteome | 1 | 2017 | 285 | 0.110 |
Why?
|
| Cell Survival | 2 | 2014 | 826 | 0.110 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2016 | 176 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 2326 | 0.100 |
Why?
|
| Caffeine | 1 | 2014 | 66 | 0.100 |
Why?
|
| Male | 14 | 2018 | 64957 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 555 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2015 | 412 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 639 | 0.090 |
Why?
|
| Female | 11 | 2023 | 70963 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2014 | 594 | 0.090 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2011 | 32 | 0.090 |
Why?
|
| Lipid Peroxidation | 3 | 2018 | 93 | 0.090 |
Why?
|
| Epithelial Cells | 2 | 2016 | 905 | 0.090 |
Why?
|
| Carcinogens | 1 | 2011 | 127 | 0.080 |
Why?
|
| Fish Oils | 1 | 2011 | 82 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1267 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 3436 | 0.080 |
Why?
|
| Carcinogens, Environmental | 1 | 2010 | 12 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 301 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2002 | 1447 | 0.070 |
Why?
|
| Cytochrome P-450 CYP1A2 Inhibitors | 1 | 2006 | 3 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2550 | 0.060 |
Why?
|
| Immunohistochemistry | 3 | 2014 | 1591 | 0.060 |
Why?
|
| Body Weight | 3 | 2015 | 987 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 4697 | 0.050 |
Why?
|
| Dinoprost | 2 | 2015 | 23 | 0.050 |
Why?
|
| Genes, Reporter | 3 | 2011 | 341 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 1105 | 0.050 |
Why?
|
| Gene Expression | 1 | 2007 | 1481 | 0.050 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 43 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 203 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12936 | 0.040 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 112 | 0.040 |
Why?
|
| Survival Rate | 1 | 2006 | 2114 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 664 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1356 | 0.040 |
Why?
|
| Parvovirus | 1 | 2000 | 6 | 0.040 |
Why?
|
| Chlamydia | 1 | 2000 | 3 | 0.040 |
Why?
|
| Mycobacterium | 1 | 2000 | 30 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 521 | 0.040 |
Why?
|
| Luciferases | 2 | 2011 | 127 | 0.040 |
Why?
|
| Enterovirus | 1 | 2000 | 48 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2018 | 15 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 1801 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 259 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2000 | 686 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2000 | 481 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2000 | 579 | 0.030 |
Why?
|
| Cell Line | 2 | 2014 | 2552 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 146 | 0.030 |
Why?
|
| Transfection | 2 | 2008 | 962 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1211 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 356 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 18 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 48 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 27 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 1363 | 0.030 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2014 | 8 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 246 | 0.030 |
Why?
|
| Inflammation | 1 | 2002 | 1489 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2014 | 53 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 571 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 119 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2017 | 4686 | 0.020 |
Why?
|
| Proteomics | 1 | 2017 | 615 | 0.020 |
Why?
|
| Neutrophils | 1 | 2015 | 371 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 1673 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 409 | 0.020 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2011 | 9 | 0.020 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2011 | 14 | 0.020 |
Why?
|
| Computational Biology | 1 | 2017 | 862 | 0.020 |
Why?
|
| Cytoprotection | 1 | 2011 | 36 | 0.020 |
Why?
|
| Microsomes | 1 | 2011 | 35 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 3748 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 2595 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 263 | 0.020 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 54 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1618 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 541 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 254 | 0.020 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2011 | 88 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2011 | 377 | 0.020 |
Why?
|
| Apoproteins | 1 | 2008 | 11 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 52 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2904 | 0.020 |
Why?
|
| Cytochromes | 1 | 2007 | 7 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2007 | 65 | 0.020 |
Why?
|
| Microsomes, Liver | 1 | 2007 | 97 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1827 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 6196 | 0.010 |
Why?
|
| Diet | 1 | 2011 | 1121 | 0.010 |
Why?
|
| Biomarkers | 1 | 2013 | 3385 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1371 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 31282 | 0.010 |
Why?
|